Surface Oncology, Inc. EBITDA 2018-2023 | SURF
Surface Oncology, Inc. ebitda from 2018 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Surface Oncology, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2022 | $-60 |
| 2021 | $-74 |
| 2020 | $63 |
| 2019 | $-56 |
| 2018 | $-8 |
| 2017 | $-45 |
| 2016 | $-17 |
| Surface Oncology, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2023-06-30 | $-24 |
| 2023-03-31 | $-19 |
| 2022-12-31 | $-21 |
| 2022-09-30 | $-23 |
| 2022-06-30 | $-24 |
| 2022-03-31 | $7 |
| 2021-12-31 | $-23 |
| 2021-09-30 | $-19 |
| 2021-06-30 | $-18 |
| 2021-03-31 | $-14 |
| 2020-12-31 | $68 |
| 2020-09-30 | $-14 |
| 2020-06-30 | $-14 |
| 2020-03-31 | $23 |
| 2019-12-31 | $-16 |
| 2019-09-30 | $-17 |
| 2019-06-30 | $-18 |
| 2019-03-31 | $-5 |
| 2018-12-31 | $-5 |
| 2018-09-30 | $-18 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $31 |
| 2017-12-31 | $-16 |
| 2017-09-30 | $-14 |
| 2017-06-30 | $-6 |
| 2017-03-31 | $-8 |
